Delivery Order SPE2DB22D3301-SPE2DB23FZ2BA
Award Date 7/27/23
Potential Completion Date 7/28/23
Potential Value $360
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $720 firm fixed price delivery order to Amerisourcebergen Drug Corporation for RESTASIS MULTIDOSE 0.05% eye drops. Performance will take place in Conshohocken, Pennsylvania from September 16 to 18, 2023. The Defense Logistics Agency manages the Department of Defense's global logistics network and supply chain, and this order for eye drops is consistent with supporting the medical needs of DOD personnel. No set aside designation or subcontractors were...
- The Defense Logistics Agency awarded a $540,000 firm fixed price delivery order to Amerisourcebergen Drug Corporation for RESTASIS 0.05% eye emulsion. The single award was issued under an indefinite-delivery/indefinite-quantity contract vehicle to supply the emulsion, a prescription eye drop medication used to treat dry eyes. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period from July 27-28, 2023. As a key logistics and procurement...
- The Defense Logistics Agency awarded a $63,391 firm fixed price delivery order to Amerisourcebergen Drug Corporation for RESTASIS 0.05% eye emulsion. The order is for 30 units of the product, which will be delivered from Amerisourcebergen's facility in Conshohocken, Pennsylvania by August 25, 2023 to support the Defense Logistics Agency's medical supply needs. Amerisourcebergen will serve as the prime contractor on the order, which was issued under an existing DLA-wide supply contract vehicle...
- The Defense Logistics Agency awarded a $16,586 delivery order to Amerisourcebergen Drug Corporation for RESTASIS 0.05% eye emulsion. As the prime contractor, Amerisourcebergen will supply 60 units of the ophthalmic solution to support DLA programs. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania under a firm fixed price contract spanning August 18 through 21, 2023. No subcontractors or set aside designations were identified. DLA manages the global supply...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $3,174 to Amerisourcebergen Drug Corporation for RESTASIS 0.05% eye emulsion. The order is for 30 units of the product to be delivered to a location in Conshohocken, Pennsylvania by September 28, 2023. The Defense Logistics Agency manages the Department of Defense's global logistics operations and works to support the supply needs of the military services. This small order for a pharmaceutical...
- <p>The Defense Logistics Agency awarded a $662 delivery order to Amerisourcebergen Drug Corporation for RESTASIS 0.05% eye emulsion. The firm fixed price order is to supply 30 units of the product. Performance will take place in Conshohocken, Pennsylvania over one day in September 2023. The Defense Logistics Agency manages the Department of Defense's global logistics operations, suggesting this order supports DOD healthcare needs. No set aside designation or subcontractors were indicated.</p>
- The Defense Logistics Agency awarded a $42,936.37 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4561400107 RESTASIS 0.05% eye emulsion in 30 count bottles. The place of performance will be Amerisourcebergen's Conshohocken, Pennsylvania facility. The order period of performance spans from July 3 to July 5, 2023. As a major provider of pharmaceuticals and medical supplies to the Department of Defense globally, this order for RESTASIS, an ophthalmic...
- The Defense Logistics Agency awarded a $1,184 firm fixed price delivery order to Amerisourcebergen Drug Corporation for RESTASIS 0.05% eye emulsion. The order is for 30 units of the product, which will be delivered from Amerisourcebergen's facility in Conshohocken, Pennsylvania by June 22, 2023 in support of the Defense Logistics Agency's medical supply needs. Amerisourcebergen will serve as the prime contractor on the order, which was issued against an unspecified government-wide acquisition...
- The Defense Logistics Agency awarded a $6,028.77 firm fixed price delivery order to Amerisourcebergen Drug Corporation for RESTASIS 0.05% eye emulsion. The delivery order was issued against an indefinite-delivery/indefinite-quantity contract vehicle to supply pharmaceutical products and services to the Department of Defense. Performance will take place in Conshohocken, Pennsylvania over a one-day period from August 8 to August 9, 2023. No subcontractors or set aside designations were identified....
- The Defense Logistics Agency awarded a $7,096.08 firm fixed price delivery order to Amerisourcebergen Drug Corporation for RESTASIS 0.05% eye emulsion. The delivery order was issued against an existing prime vendor contract vehicle to supply 30 units of the ophthalmic drug to a facility located in Conshohocken, Pennsylvania. Performance is required from August 18-21, 2023. No subcontractors or set aside designations were specified. The Defense Logistics Agency manages the global supply chain for...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB23FZ2BADelivery Order
The Defense Logistics Agency awarded a $360,160 delivery order to Amerisourcebergen Drug Corporation for RESTASIS 0.05% eye emulsion. The firm fixed price order is for 30 units of the product and will be fulfilled by Amerisourcebergen from its facility in Conshohocken, Pennsylvania by July 28, 2023. The Defense Logistics Agency manages the Department of Defense's global logistics operations and works to support all military services and combatant commands. This order for RESTASIS eye drops is likely in support of DLA's medical supply chain responsibilities. No set aside designation or subcontractors were indicated in the award information.
Generated 12/15/23, 9:41 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $360 | 7/27/23 |